CU in the News

Local Covid vaccine ‘ready for clinical trials’

The locally developed Covid-19 vaccine – ChulaCov19 – will be ready for human trials this month after proving to be effective in lab tests.

Local Covid vaccine ‘ready for clinical trials’

In a Facebook post, deputy government spokesperson Traisulee Traisoranakul said the vaccine, developed by Dr Kiat Ruxrungtham from Chulalongkorn University, will be tested on 100 volunteers this month.

The clinical trial also aims to work out the right dosage for immunization. Once the trial is successfully completed, the first lot of vaccines will be produced in the US, before Thailand’s BioNet-Asia begins mass production in September.

Chula’s encouragement and support for research is excellent for teachers, students, and the public.

Associate Professor Dr. Suchana Chavanich Faculty of Science, Chulalongkorn University